The same active ingredient – ivermectin – in Merial’s IVOMEC® (ivermectin) product
range for farm animals is also used to treat river blindness in humans.
More than 1 billion doses of Merial vaccines to combat avian influenza have been
dispensed in countries such as Mexico and Vietnam.
Merial produces FRONTLINE®, the Number 1 flea and tick product for dogs and
cats in the world.
Merial has the first highly selective coxib nonsteroidal anti-inflammatory drug
(NSAID) developed specifically for dogs.
All PUREVAX® feline vaccines are non-adjuvanted.
Merial’s heritage includes the first industrial scale production of any animal health vaccine – foot-and-mouth disease in 1952.
Merial has the only FDA-approved treatment for equine gastric ulcers.
Merial developed the first cattle endectocide pour-on that is highly effective against
internal and external parasites with zero milk withdrawal.
Merial maintains antigen vaccine banks to help governments around the world respond
rapidly to outbreaks of diseases such as foot-and-mouth disease.
Merial received a breakthrough conditional license for our Bluetongue vaccine (BTVPUR
AlSap™), developed in only 18 months.